Nyemb SRL
The score of Nyemb shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +61 % Total assets +40 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Nyemb's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 109,622 € | ||||
| Equity | 514,571 € | ||||
| Cash | 27,459 € | ||||
| EBITDA | 232,525 € | ||||
| Total assets | €1.15m |
Filed annual accounts
- Year ended 31 Dec 2025filed on 31 Jul 2026
- Year ended 31 Dec 2024filed on 28 Aug 2025
- Year ended 31 Dec 2023filed on 26 Aug 2024
- Year ended 31 Dec 2022filed on 13 Jul 2023
- Year ended 31 Dec 2021filed on 20 Jul 2022
Nyemb's financial analysis
- Solvency44.6%sector median: 58.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Nyemb
Nyemb's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0879.376.957
- VAT number
- BE0879376957
- Peppol
- Registered · 0208:0879376957 · as of 08 Nov 2026
- Legal form
- SRL
- Incorporated
- 14 Feb 2006
- Registered office
- 7503 Tournai
- Latest accounts
- 2025 · filed on 31 Jul 2026
- Activity
- Research and experimental development on biotechnology (NACE 72101)
Nyemb (SRL) has been based in Tournai since 2006, active in: research and experimental development on biotechnology. For 2025, it reports a net profit of 109,622 € and equity of 514,571 €; its revenue is not published. Its solvency stands at 44.6%, below the median of its sector (58.2%).
Companies similar to Nyemb
Companies in the same business, of comparable size and area, outside its group.
- ProtonW.be Research and experimental development on natural sciences and engineering Charleroi · balance sheet €1.27m
- Dokter Fries Claerhout Research and experimental development on natural sciences and engineering Poperinge · balance sheet 906,181 €
- IR 4 Research and experimental development on natural sciences and engineering Auderghem · balance sheet 865,084 €
- DR. Johan Vanden Broucke Research and experimental development on natural sciences and engineering Ypres · balance sheet €1.88m
- Temple OrthoBiologics Research and experimental development on natural sciences and engineering Liège · balance sheet 692,165 €
- CTTec Research and experimental development on natural sciences and engineering Menen · balance sheet 259,750 €
- NasaPharm Research and experimental development on natural sciences and engineering Blegny · balance sheet 606,267 €
- Asylia Diagnostics Research and experimental development on natural sciences and engineering Leuven · balance sheet 552,090 €
Frequently asked questions about Nyemb
What is the revenue of Nyemb?
Nyemb files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Nyemb?
In Belgium, the VAT number is the company number prefixed with BE: BE0879376957 for Nyemb, if the company is VAT-registered. Its company number (CBE) is 0879.376.957.
Where is the registered office of Nyemb?
According to the CBE register, the registered office of Nyemb is in 7503 Tournai.
What is the equity of Nyemb?
At the close of the 2025 financial year, the equity of Nyemb amounts to 514,571 €, a solvency of 44.6% of total assets.
Who manages Nyemb?
The register lists 1 active mandates at Nyemb. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Nyemb
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →